Literature DB >> 16112939

Hybrid coronary artery revascularization: logistics and program development.

Guy J Friedrich1, Patricja Jonetzko, Nikos Bonaros, Thomas Schachner, Michael Danzmayr, Ruth Kofler, G Laufer, O Pachinger, Johannes Bonatti.   

Abstract

Planning hybrid coronary artery revascularization--a combination of cardiac surgery with percutaneous procedures--requires, at first sight, a very complex logistical setup. Technical and equipment related details should be defined as early as possible in order to have time for training of all OR personnel involved. The most challenging aspect in OR-located hybrid coronary revascularization remains a very close cooperation of cardiac surgeons and interventional cardiologists. This teamwork does include indication findings and subsequent referral of multivessel coronary artery disease patients to hybrid procedures, as well as high individual flexibility of interventionalists and surgeons. The major prerequisite for this cooperation is a mutual acceptance of different revascularization approaches and the intent to combine their most striking advantages. Intraoperative graft angiography during coronary artery bypass grafting (CABG) procedures is one important step toward simultaneous hybrid coronary revascularization procedures. We describe our experience with on table angiography using a mobile C-arm for intraoperative imaging. This fluoroscopy system can in selected cases be used for simultaneous hybrid procedures.

Entities:  

Mesh:

Year:  2005        PMID: 16112939     DOI: 10.1532/HSF98.20051134

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  2 in total

1.  Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques.

Authors:  Robert S Poston; Richard Tran; Michael Collins; Marty Reynolds; Ingrid Connerney; Barry Reicher; David Zimrin; Bartley P Griffith; Stephen T Bartlett
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

2.  [Not Available].

Authors:  Ahmed A Alsaddique
Journal:  Open Cardiovasc Med J       Date:  2009-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.